SHBG and TRT: What the hormone actually does to your testosterone
Quick answer
The creator reports an SHBG level of approximately 4.4 to 4.9 nmol/L while on testosterone replacement therapy, a reading well below the standard male reference range of 10 to 57 nmol/L. At this level, the ratio of free to bound androgen is significantly altered, raising questions about erythrocytosis risk, cardiovascular signaling, and androgen receptor dynamics that extend beyond what lifestyle modifications alone are likely to address. Any management decisions around severely suppressed SHBG in the context of exogenous testosterone use should involve full panel review and physician oversight, not self-directed mitigation strategies.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @dt.roth actually say?
The creator disclosed that their SHBG came back somewhere between 4.4 and 4.9, which is genuinely quite low. They acknowledged that while low SHBG means more free testosterone is available, it comes with trade-offs: reduced prostate and heart health protection. Their conclusion was that "if it is low, you can do other things to mitigate side effects" rather than treating the number as a dealbreaker. That framing is worth examining carefully.
To be clear, this isn't a dramatic or reckless claim. It's a personal reflection with a qualifying disclaimer: "this is my opinion." That kind of epistemic humility is rare in hormone content on TikTok. But opinion or not, the underlying assumptions deserve scrutiny because low SHBG in the context of exogenous testosterone carries real clinical implications that go beyond lifestyle tweaks.
Does the science back this up?
Partly. The basic physiology is correct: SHBG binds sex hormones, and low SHBG correlates with higher free testosterone bioavailability. The cardiovascular and prostate concern is also real, though it's more nuanced than the creator suggests.
SHBG has been identified as an independent predictor of cardiovascular risk in several large cohort studies. Ding et al. (2015, JAMA Internal Medicine) found that low SHBG was associated with increased risk of type 2 diabetes and metabolic syndrome, both of which are cardiovascular risk amplifiers. Separately, research from Holmberg et al. (2012, NEJM) and later analyses from the SPCG-4 trial suggested SHBG interacts with androgen signaling in prostate tissue in ways that aren't fully understood.
The idea that lifestyle interventions can "mitigate" these risks isn't baseless. Diet, exercise, and weight management do influence SHBG levels and metabolic health. But the claim that these measures can fully offset the risks of sustained, very low SHBG while on TRT lacks strong clinical evidence. A level of 4.4 to 4.9 is below most laboratory reference ranges by a significant margin, and that context is missing from the video.
What did they get wrong (or right)?
They got the basic mechanism right. Low SHBG does increase free testosterone, and that's the reason some TRT users end up with this pattern: exogenous testosterone suppresses SHBG production, which then loops back to change the free-to-total testosterone ratio.
What's missing is precision. SHBG in the range of 4 to 5 nmol/L isn't just "low." It's severely low. Normal adult male ranges typically run from 10 to 57 nmol/L. At these levels, erythrocytosis risk, hematocrit elevation, and potential blood viscosity changes become more clinically relevant, not just prostate and cardiac signaling. The creator doesn't mention hematocrit, which is arguably the most monitored safety marker in TRT management.
The suggestion to "do other things to mitigate" is vague enough to be either reasonable or misleading depending on what those things are. If they mean regular bloodwork, cardiovascular exercise, and physician monitoring, that's defensible. If they mean supplements or anecdotal protocols circulating in TRT communities, the evidence base is thin.
What should you actually know?
SHBG is not just a testosterone transport protein. It has its own receptor activity and influences signaling in ways researchers are still mapping. A review by Hammond (2016, Journal of Endocrinology) summarizes the emerging evidence that SHBG acts directly on tissues, not just as a passive carrier. Treating a very low SHBG reading as something to simply route around with lifestyle changes underestimates what we don't yet know.
If you're on TRT and your SHBG comes back this low, the appropriate response is a conversation with a licensed provider who can interpret the full panel, including free testosterone, total testosterone, estradiol, hematocrit, PSA, and lipids together. No single number in isolation tells the whole story.
- SHBG below 10 nmol/L is considered clinically low by most endocrinology guidelines.
- Low SHBG is associated with insulin resistance and metabolic syndrome independent of testosterone levels.
- Lifestyle factors like alcohol reduction, weight loss, and dietary changes can modestly raise SHBG, but the effect size in severely low cases is limited.
- Exogenous testosterone itself tends to suppress SHBG, which can create a feedback loop that's difficult to reverse without adjusting the TRT protocol.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For SHBG and TRT: What the hormone actually does to your testosterone, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
SHBG and TRT: What the hormone actually does to your testosterone should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator reports an SHBG level of approximately 4.
FormBlends verdict
The creator reports an SHBG level of approximately 4.4 to 4.9 nmol/L while on testosterone replacement therapy, a reading well below the standard male reference range of 10 to 57 nmol/L. At this level, the ratio of free to bound androgen is significantly altered, raising questions about erythrocytosis risk, cardiovascular signaling, and androgen receptor dynamics that extend beyond what lifestyle modifications alone are likely to address. Any management decisions around severely suppressed SHBG in the context of exogenous testosterone use should involve full panel review and physician oversight, not self-directed mitigation strategies.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator reports an SHBG level of approximately 4.4 to 4.9 nmol/L while on testosterone replacement therapy, a reading well below the standard male reference range of 10 to 57 nmol/L. At this level, the ratio of free to bound androgen is significantly altered, raising questions about erythrocytosis risk, cardiovascular signaling, and androgen receptor dynamics that extend beyond what lifestyle modifications alone are likely to address. Any management decisions around severely suppressed SHBG in the context of exogenous testosterone use should involve full panel review and physician oversight, not self-directed mitigation strategies.
- SHBG between 4 and 5 nmol/L is severely low by clinical standards; the typical male reference range runs from 10 to 57 nmol/L according to most endocrinology lab references.
- Exogenous testosterone suppresses SHBG production, meaning TRT itself can create or worsen low SHBG in a feedback loop that is difficult to reverse without adjusting the protocol.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- SHBG between 4 and 5 nmol/L is severely low by clinical standards; the typical male reference range runs from 10 to 57 nmol/L according to most endocrinology lab references.
- Exogenous testosterone suppresses SHBG production, meaning TRT itself can create or worsen low SHBG in a feedback loop that is difficult to reverse without adjusting the protocol.
- Ding et al. (2015, JAMA Internal Medicine) found low SHBG independently associated with metabolic syndrome and type 2 diabetes risk, both of which amplify cardiovascular burden.
- Hammond (2016, Journal of Endocrinology) documented that SHBG has direct receptor-mediated activity in tissues, meaning it is not simply a passive carrier protein, and its suppression has effects beyond free testosterone math.
- Lifestyle changes such as alcohol reduction, weight loss, and lower refined carbohydrate intake can raise SHBG modestly, but evidence for meaningful correction in severely suppressed cases while on TRT is limited.
- Hematocrit and red blood cell changes are among the most monitored safety markers in TRT management, and very low SHBG with high free testosterone levels can contribute to erythrocytosis risk that was not mentioned in the video.
- Anyone managing an SHBG reading this far outside normal range on a hormone protocol should have that interpreted by a licensed provider in the context of a full panel, not addressed with self-directed mitigation alone.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
DT Roth · TikTok creator
17.4K views on this video
SHBG???? - #shbg #fyp #lifexmd #test #testosteronetherapy #testosteronereplacement #hgh #gear
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by DT Roth, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.